Literature DB >> 19450585

MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.

Zheng Zhang1, Huimin Peng, Junxia Chen, Xin Chen, Fei Han, Xiaoming Xu, Xiaoyan He, Ning Yan.   

Abstract

Diabetic nephropathy (DN) is a major diabetic complication. But the initiating molecular events triggering DN are unknown. Recent researches have addressed the role of microRNAs in diabetes and its complications. In this study, we looked for microRNAs expression during early DN, and showed microRNA-21 (miR-21) expression was downregulated in response to early DN in vitro and in vivo. Over-expression of miR-21 inhibited proliferation of mesangial cells and decreased the 24-h urine albumin excretion rate in diabetic db/db mice. Moreover, we identified PTEN as a target of miR-21. We also found PI3K and p-Akt increased in miR-21 treated mesangial cells and db/db mice. Overall, these studies for the first time provide evidence for the potential role of miR-21 in early DN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450585     DOI: 10.1016/j.febslet.2009.05.021

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  61 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

2.  Observation of miRNA gene expression in zebrafish embryos by in situ hybridization to microRNA primary transcripts.

Authors:  Xinjun He; Yi-Lin Yan; April DeLaurier; John H Postlethwait
Journal:  Zebrafish       Date:  2011-02-02       Impact factor: 1.985

3.  Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.

Authors:  Marimuthu Subathra; Midhun Korrapati; Lauren A Howell; John M Arthur; James A Shayman; Rick G Schnellmann; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

4.  Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.

Authors:  Le Zhang; Siyi He; Shaodong Guo; Wei Xie; Rong Xin; Hua Yu; Fan Yang; Jing Qiu; Di Zhang; Shiwen Zhou; Kebin Zhang
Journal:  J Diabetes Complications       Date:  2014-01-11       Impact factor: 2.852

5.  Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.

Authors:  Hongmei Zhu; Siu Wai Leung
Journal:  Diabetologia       Date:  2015-02-13       Impact factor: 10.122

Review 6.  Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.

Authors:  Alieh Gholaminejad; Hossein Abdul Tehrani; Mohammad Gholami Fesharaki
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

Review 7.  MicroRNAs and the glomerulus.

Authors:  Mitsuo Kato; Jung Tak Park; Rama Natarajan
Journal:  Exp Cell Res       Date:  2012-03-05       Impact factor: 3.905

8.  MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction.

Authors:  Chenfei Zheng; Ji Zhang; Xinxin Chen; Jianna Zhang; Xiaokai Ding; Xiaohan You; Lin Fan; Chaosheng Chen; Ying Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

9.  MicroRNA-21 in glomerular injury.

Authors:  Jennifer Y Lai; Jinghui Luo; Christopher O'Connor; Xiaohong Jing; Viji Nair; Wenjun Ju; Ann Randolph; Iddo Z Ben-Dov; Regina N Matar; Daniel Briskin; Jiri Zavadil; Robert G Nelson; Thomas Tuschl; Frank C Brosius; Matthias Kretzler; Markus Bitzer
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

10.  miRNAs in newt lens regeneration: specific control of proliferation and evidence for miRNA networking.

Authors:  Kenta Nakamura; Nobuyasu Maki; Albert Trinh; Heidi W Trask; Jiang Gui; Craig R Tomlinson; Panagiotis A Tsonis
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.